This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2022 Feb 25;37(3):602-604.

doi: 10.1093/ndt/gfab321.

Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients

Naomi Nacasch¹, Keren Cohen-Hagai^{1

2}, Sydney Benchetrit^{1

2}, Tali Zitman-Gal^{1

2}, Yael Einbinder^{1

2}, Daniel Erez^{2

3}, Tzipi Hornik-Lurie⁴, Shira Goldman^{5

2}, Tatiana Tanasiychuk⁶, Victor Frajewicki⁶, Sophie Magen^{7

8}, Yonit Wiener-Well^{9

8}, Alon Bnaya^{10

8}, Linda Shavit^{10

8}

Affiliations

Affiliations

¹ Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel.
² Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
³ Department of Internal Medicine D, Meir Medical Center, Kfar Saba, Israel.
⁴ Data Research Department, Meir Medical Center, Kfar Saba, Israel.
⁵ Department of Nephrology and Hypertension, Rabin Medical Center, Pathach Tikva, Israel.
⁶ Department of Nephrology and Hypertension, Carmel Medical Center, Haifa, Israel.
⁷ Clinical Endocrinology Laboratory, Shaare Zedek Medical Center, Jerusalem, Israel.
⁸ Hebrew University of Jerusalem, Jerusalem, Israel.
⁹ Infectious Disease Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
¹⁰ Institute of Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel.

PMID: 34788861
PMCID: PMC8767896
DOI: 10.1093/ndt/gfab321

Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients

Naomi Nacasch et al. Nephrol Dial Transplant. 2022.

. 2022 Feb 25;37(3):602-604.

doi: 10.1093/ndt/gfab321.

Authors

Naomi Nacasch¹, Keren Cohen-Hagai^{1

2}, Sydney Benchetrit^{1

2}, Tali Zitman-Gal^{1

2}, Yael Einbinder^{1

2}, Daniel Erez^{2

3}, Tzipi Hornik-Lurie⁴, Shira Goldman^{5

2}, Tatiana Tanasiychuk⁶, Victor Frajewicki⁶, Sophie Magen^{7

8}, Yonit Wiener-Well^{9

8}, Alon Bnaya^{10

8}, Linda Shavit^{10

8}

Affiliations

¹ Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba, Israel.
² Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
³ Department of Internal Medicine D, Meir Medical Center, Kfar Saba, Israel.
⁴ Data Research Department, Meir Medical Center, Kfar Saba, Israel.
⁵ Department of Nephrology and Hypertension, Rabin Medical Center, Pathach Tikva, Israel.
⁶ Department of Nephrology and Hypertension, Carmel Medical Center, Haifa, Israel.
⁷ Clinical Endocrinology Laboratory, Shaare Zedek Medical Center, Jerusalem, Israel.
⁸ Hebrew University of Jerusalem, Jerusalem, Israel.
⁹ Infectious Disease Unit, Shaare Zedek Medical Center, Jerusalem, Israel.
¹⁰ Institute of Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel.

PMID: 34788861
PMCID: PMC8767896
DOI: 10.1093/ndt/gfab321

Erratum in

Correction to: Comparison of long-term antibody response to mRNA SARS-CoV-2 vaccine among peritoneal dialysis and hemodialysis patients.
Einbinder Y, Hornik-Lurie T, Cohen-Hagai K, Goldman S, Tanasiychuk T, Nacasch N, Erez D, Magen S, Zitman-Gal T, Wiener-Well Y, Frajewicki V, Benchetrit S, Shavit L, Bnaya A. Einbinder Y, et al. Nephrol Dial Transplant. 2022 Aug 22;37(9):1780. doi: 10.1093/ndt/gfac141. Nephrol Dial Transplant. 2022. PMID: 35639832 Free PMC article. No abstract available.

No abstract available

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

Israeli Ministry of Health

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal